EuroAPI is a global leader in the production and marketing of active pharmaceutical ingredients (APIs), offering a portfolio of over 200 products to meet diverse patient needs worldwide. EuroAPI specializes in complex chemistries and contract development and manufacturing services, with a focus on sustainable and innovative solutions. With annual sales of about $1 billion and operations across multiple European sites, EuroAPI employs over 3,000 professionals, driving growth in the API and CDMO sectors.• Managed and nurtured relationships with key clients in the pharmaceutical industry to drive business growth and customer satisfaction.• Developed tailored strategies for each key account to meet their specific needs in the active pharmaceutical ingredients (API) sector.• Collaborated with cross-functional teams to ensure the delivery of high-quality API solutions in line with client requirements.• Conducted regular client meetings and presentations to showcase EuroAPI's product offerings and innovations.• Identified new business opportunities within key accounts, leading to increased revenue and market share.• Provided expert insights and feedback to the product development team to align offerings with market needs and trends.• Ensured consistent client satisfaction by addressing concerns and facilitating effective solutions in a timely manner.• Kept abreast of industry developments to maintain a competitive edge and offer the latest solutions to clients.• Played a key role in contract negotiations and renewals, ensuring favourable terms for both EuroAPI and its clients.• Contributed to the development and implementation of EuroAPI's strategic account management processes and best practices.

Novasep is a global provider of production and purification solutions for the life sciences and chemical industries. The company specialises in the development and contract manufacturing of small molecule active ingredients and biomolecules, leveraging advanced technologies such as hazardous chemistry, asymmetric synthesis, and process chromatography. With a history of innovation, Novasep is dedicated to meeting complex molecule purity challenges.• Led team that developed new business strategy to maximise profitable growth for Small Molecule business that involved target account selection, project screening criteria and pricing strategy• Used commercially available market data GlobalData to devise prioritized account target list and supported team• Pioneered White Papers to provide thought leadership (in conjunction with Informa)• Continual improvement of LinkedIn & Sales Navigator to identify anf nurture leads• Part of team with consultants that customised use of Microsoft Dynamics CRM to capture more business from prospects and customers• Introduced third party prospection and lead qualification

• Responsible for sales of custom synthesis products to key accounts and biopharma accounts• Technologies: small molecule highly potent/cytotoxic, hazardous chemistry and chromatographic purifications, ADCs• Responsible for €20 million sales growing at 10% per annum with on target sales performance last 3 years

Developing new business for Chemical division of Lonza Custom Manufacturing in UK, Ireland, Scandinavia & Netherlands.Lonza is a leading global provider in the pharmaceutical, biotech, and nutrition sectors, specializing in the development and manufacturing of active pharmaceutical ingredients and innovative dosage forms. Founded in 1897 and operating worldwide with a workforce of around 17,500, Lonza offers technological and scientific expertise to deliver new medicines and support healthier lifestyles.• Key account manager responsible for UK based accounts with $60 million business in 2013• Developed new business in UK, Ireland & Scandinavia - Contacts at 200 at large and small Pharma accounts- Introduced 8 new clients, across 3 technologies - Generated 100 new project enquiries with 20 new project wins• Technologies: biologics, small molecules, peptides and antibody-drug conjugates• Leading multi-functional and multi –national project acquisition teams

• Fine chemicals agent/distributor to UK & Irish pharmaceutical market• Responsible for £5 million sales of - Bulk APIs (Boehringer Ingelheim)- Custom synthesis (Omnichem)- Functional excipients (Gattefossé)• Developed team of 3 field sales representatives & 1 inside sales • Developed new business with Big Pharma and Biotech customers• Acquired new Principals from Europe, US & China

New business development fornon-GMP pharmaceutical intermediates.Set up first company web site.

Water treament chemical services and business development in West Midlands.